Metraipolis › archive › dc_0b8f96cd772f
Development and clinical validation of an ERA-CRISPR/Cas12a assay for the rapid detection of 14 high-risk HPV types — Europe PMC PMID:41451985
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41451985
- DOI
- 10.1128/spectrum.03036-25
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T09:55:43.189Z
- SHA-256 of the archived text
7c793595ac32365f1380bd315579aab13b089d84f4db930a6ee14bc409ac1d97- Stable URL of this page
https://metraipolis.com/documento/dc_0b8f96cd772f
How to cite
Development and clinical validation of an ERA-CRISPR/Cas12a assay for the rapid detection of 14 high-risk HPV types — Europe PMC PMID:41451985 — Europe PMC (en), https://europepmc.org/article/MED/41451985 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0b8f96cd772f (Metraipolis archive dc_0b8f96cd772f, sha256 7c793595ac32365f1380bd315579aab13b089d84f4db930a6ee14bc409ac1d97)
BibTeX
@misc{dc0b8f96cd772f,
title = {Development and clinical validation of an ERA-CRISPR/Cas12a assay for the rapid detection of 14 high-risk HPV types — Europe PMC PMID:41451985},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41451985},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0b8f96cd772f; sha256 7c793595ac32365f1380bd315579aab13b089d84f4db930a6ee14bc409ac1d97},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41451985. Agents can read the archived copy with the MCP tool read_document.